PRDX2 and hypertensive disorder: To investigate whether PRDX2 is sufficient to counteract ROS in erythrocytes from hypertensive (HTN) patients, membrane skeletons from erythrocytes of HTN patients and normotensive individuals (NTI) were analyzed via Western blotting.